Barclays’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $762M | Sell |
2,817,725
-456,917
| -14% | -$136M | 0.18% | 79 |
|
|
2025
Q4 | $1.08B | Sell |
3,274,642
-515,372
| -14% | -$175M | 0.26% | 52 |
|
|
2025
Q3 | $1.31B | Sell |
3,790,014
-666,660
| -15% | -$202M | 0.28% | 41 |
|
|
2025
Q2 | $1.39B | Buy |
4,456,674
+199,877
| +5% | +$76.4M | 0.32% | 32 |
|
|
2025
Q1 | $2.23B | Buy |
4,256,797
+349,006
| +9% | +$178M | 0.63% | 21 |
|
|
2024
Q4 | $1.98B | Buy |
3,907,791
+696,010
| +22% | +$395M | 0.55% | 24 |
|
|
2024
Q3 | $1.88B | Buy |
3,211,781
+46,607
| +1% | +$26.4M | 0.5% | 21 |
|
|
2024
Q2 | $1.61B | Sell |
3,165,174
-727,141
| -19% | -$356M | 0.49% | 23 |
|
|
2024
Q1 | $1.93B | Buy |
3,892,315
+450,739
| +13% | +$229M | 0.67% | 21 |
|
|
2023
Q4 | $1.81B | Sell |
3,441,576
-11,696
| -0.3% | -$6.24M | 0.66% | 19 |
|
|
2023
Q3 | $1.74B | Sell |
3,453,272
-40,828
| -1% | -$20.1M | 1.08% | 11 |
|
|
2023
Q2 | $1.68B | Buy |
3,494,100
+2,011,029
| +136% | +$983M | 1.06% | 12 |
|
|
2023
Q1 | $701M | Sell |
1,483,071
-2,131,695
| -59% | -$1.03B | 0.32% | 28 |
|
|
2022
Q4 | $1.92B | Buy |
3,614,766
+1,327,564
| +58% | +$703M | 0.86% | 13 |
|
|
2022
Q3 | $1.16B | Buy |
2,287,202
+627,494
| +38% | +$330M | 1.26% | 8 |
|
|
2022
Q2 | $852M | Sell |
1,659,708
-507,866
| -23% | -$255M | 0.52% | 28 |
|
|
2022
Q1 | $1.11B | Sell |
2,167,574
-1,314,302
| -38% | -$634M | 0.87% | 14 |
|
|
2021
Q4 | $1.75B | Buy |
3,481,876
+216,364
| +7% | +$97.9M | 0.65% | 21 |
|
|
2021
Q3 | $1.28B | Buy |
3,265,512
+753,016
| +30% | +$312M | 0.57% | 24 |
|
|
2021
Q2 | $1.01B | Buy |
2,512,496
+366,364
| +17% | +$146M | 0.48% | 24 |
|
|
2021
Q1 | $799M | Buy |
2,146,132
+306,836
| +17% | +$106M | 0.43% | 29 |
|
|
2020
Q4 | $645M | Sell |
1,839,296
-298,923
| -14% | -$100M | 0.34% | 43 |
|
|
2020
Q3 | $667M | Buy |
2,138,219
+690,477
| +48% | +$212M | 0.4% | 38 |
|
|
2020
Q2 | $427M | Sell |
1,447,742
-69,881
| -5% | -$20M | 0.33% | 43 |
|
|
2020
Q1 | $378M | Sell |
1,517,623
-492,067
| -24% | -$135M | 0.3% | 54 |
|
|
2019
Q4 | $591M | Sell |
2,009,690
-281,002
| -12% | -$73.5M | 0.33% | 47 |
|
|
2019
Q3 | $498M | Buy |
2,290,692
+371,765
| +19% | +$89.7M | 0.31% | 42 |
|
|
2019
Q2 | $468M | Buy |
1,918,927
+362,719
| +23% | +$87.2M | 0.29% | 57 |
|
|
2019
Q1 | $385M | Buy |
1,556,208
+143,972
| +10% | +$36.7M | 0.27% | 55 |
|
|
2018
Q4 | $352M | Sell |
1,412,236
-234,225
| -14% | -$61.9M | 0.27% | 54 |
|
|
2018
Q3 | $438M | Buy |
1,646,461
+447,241
| +37% | +$116M | 0.3% | 46 |
|
|
2018
Q2 | $294M | Sell |
1,199,220
-623,875
| -34% | -$150M | 0.25% | 58 |
|
|
2018
Q1 | $390M | Sell |
1,823,095
-246,258
| -12% | -$56.2M | 0.3% | 57 |
|
|
2017
Q4 | $456M | Buy |
2,069,353
+974,875
| +89% | +$207M | 0.37% | 37 |
|
|
2017
Q3 | $214M | Buy |
1,094,478
+53,268
| +5% | +$10.3M | 0.22% | 60 |
|
|
2017
Q2 | $193M | Sell |
1,041,210
-58,573
| -5% | -$10.3M | 0.21% | 64 |
|
|
2017
Q1 | $180M | Buy |
1,099,783
+439,784
| +67% | +$72M | 0.2% | 74 |
|
|
2016
Q4 | $106M | Buy |
659,999
+15,181
| +2% | +$2.27M | 0.11% | 141 |
|
|
2016
Q3 | $90.3M | Sell |
644,818
-419,406
| -39% | -$58.7M | 0.1% | 151 |
|
|
2016
Q2 | $150M | Buy |
1,064,224
+195,682
| +23% | +$26.1M | 0.2% | 79 |
|
|
2016
Q1 | $111M | Sell |
868,542
-22,925
| -3% | -$2.71M | 0.17% | 100 |
|
|
2015
Q4 | $104M | Buy |
891,467
+102,473
| +13% | +$12M | 0.13% | 138 |
|
|
2015
Q3 | $91.5M | Sell |
788,994
-381,654
| -33% | -$45.7M | 0.11% | 158 |
|
|
2015
Q2 | $143M | Sell |
1,170,648
-197,189
| -14% | -$23.3M | 0.16% | 98 |
|
|
2015
Q1 | $161M | Sell |
1,367,837
-36,333
| -3% | -$4.04M | 0.19% | 85 |
|
|
2014
Q4 | $142M | Buy |
1,404,170
+21,601
| +2% | +$2.05M | 0.14% | 113 |
|
|
2014
Q3 | $119M | Buy |
1,382,569
+438,140
| +46% | +$37M | 0.11% | 133 |
|
|
2014
Q2 | $76.5M | Sell |
944,429
-243,717
| -21% | -$19.2M | 0.08% | 197 |
|
|
2014
Q1 | $96.2M | Buy |
1,188,146
+142,724
| +14% | +$10.7M | 0.11% | 156 |
|
|
2013
Q4 | $78.4M | Sell |
1,045,422
-144,630
| -12% | -$10.4M | 0.08% | 211 |
|
|
2013
Q3 | $84.5M | Sell |
1,190,052
-48,505
| -4% | -$3.47M | 0.1% | 160 |
|
|
2013
Q2 | $81.1M | Buy |
+1,238,557
| New | +$77.1M | 0.1% | 147 |
|
Other funds holding UNH
VCM
VPM
Barclays's UNH Position: Q1 2026 in Review
Barclays reduced its UnitedHealth (UNH) stake by 14% in Q1 2026, selling an estimated $136M and leaving 2,817,725 shares worth $762M. The position accounts for 0.18% of the portfolio, ranked #79.
Barclays first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.23B in Q1 2025. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- Barclays held 2,817,725 shares of UnitedHealth worth $762M as of Q1 2026.
- Barclays sold 456,917 UnitedHealth shares in Q1 2026, an estimated $136M.
- UnitedHealth made up 0.18% of Barclays's portfolio in Q1 2026, its #79 holding.
- Barclays first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
- Barclays's UnitedHealth position peaked at $2.23B in Q1 2025.
- 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.